Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKCA | STOK | RAPP | ||
| Company | Akcea Therapeutics Inc | Stoke Therapeutics Inc | Rapport Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.15 | 29.35 | 35.62 | ||
| High | 18.17 | 30.52 | 39.17 | ||
| Low | 18.13 | 29.30 | 35.61 | ||
| Latest | 18.17 | 29.82 | 38.40 | ||
| Change | +0.03 | +0.46 | +3.19 | ||
| % Change | +0.17% | +1.57% | +9.06% | ||
| Volume | 815,300 | 478,800 | 255,600 | ||
| 20-Day Average Volume | 661,490 | 550,080 | 301,540 | ||
| Previous Close | 18.14 | 29.36 | 35.21 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.14 | 29.91 | 36.95 | ||
| 20-Day Raw Stochastic | 70.59% | 41.57% | 67.80% | ||
| 20-Day Relative Strength | 73.10 | 45.07 | 55.53 | ||
| Weighted Alpha | -23.90 | +93.60 | +131.35 | ||
| Today's Opinion | 72% Buy | 56% Sell | 100% Buy | ||
| Previous Opinion | 64% Buy | 56% Sell | 72% Buy | ||
| Last Month's Opinion | 8% Buy | 8% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 10/02/20 | -0.63% since 06/05/26 | +6.37% since 06/05/26 | ||
| Low | 18.08 on 10/05/20 | 28.12 on 06/11/26 | 33.51 on 06/11/26 | ||
| High | 18.17 on 10/09/20 | 30.52 on 06/12/26 | 39.17 on 06/12/26 | ||
| 1-Month | |||||
| %Chg | +0.17% since 09/09/20 | -8.22% since 05/12/26 | +3.11% since 05/12/26 | ||
| Low | 18.05 on 09/21/20 | 28.02 on 05/19/26 | 33.51 on 06/11/26 | ||
| High | 18.22 on 09/28/20 | 32.41 on 05/13/26 | 40.72 on 05/27/26 | ||
| 3-Month | |||||
| %Chg | +36.72% since 07/09/20 | -18.26% since 03/12/26 | +33.94% since 03/12/26 | ||
| Low | 9.81 on 08/05/20 | 28.02 on 05/19/26 | 26.01 on 03/19/26 | ||
| High | 19.65 on 08/31/20 | 37.49 on 03/13/26 | 40.92 on 04/17/26 | ||
| 6-Month | |||||
| %Chg | +11.88% since 04/09/20 | -7.93% since 12/12/25 | +26.86% since 12/12/25 | ||
| Low | 9.81 on 08/05/20 | 25.21 on 01/12/26 | 25.21 on 02/05/26 | ||
| High | 19.65 on 08/31/20 | 40.22 on 03/10/26 | 40.92 on 04/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,846,054 | 1,857,249 | 1,836,556 | ||
| Shares Outstanding, K | 101,599 | 62,282 | 47,827 | ||
| Annual Sales | 488,540,000 | 184,420,000 | 0 | ||
| Annual Net Income | 40,770,000 | -6,890,000 | -111,480,000 | ||
| Last Quarter Sales | 22,380,000 | 6,230,000 | 20,000,000 | ||
| Last Quarter Net Income | -49,580,000 | -50,000,000 | -19,860,000 | ||
| 60-Month Beta | 1.45 | 1.17 | 0.97 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 08/04/20 | -0.79 on 05/07/26 | -0.42 on 05/07/26 | ||
| Earnings Date | 11/03/20 | 08/11/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||